<p>XTL Biopharmaceuticals Ltd. has announced the resignation of Chief Financial Officer Itay Weinstein, effective December 11, 2025. Niv Segal, who brings over 12 years of financial management experience, has been appointed as the new CFO. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. XTL Biopharmaceuticals Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-118747), on December 05, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

XTLB

<p>XTL Biopharmaceuticals Ltd. announced the resignation of CFO Itay Weinstein, effective December 11, 2025, and appointed Niv Segal as the new CFO, bringing over 12 years of financial management experience.</p>

XTL Biopharmaceuticals Appoints Niv Segal as Chief Financial Officer